Global Transcatheter Mitral Valve Replacement (TMVR) Market 2024 by Company, Regions, Type and Application, Forecast to 2030
TMVR, also known as transcatheter mitral valve replacement is a way of replacing the mitral valve in the heart without the need for conventional open-heart surgery. TMVR transcatheter mitral valve replacement is a treatment for mitral valve stenosis (tight mitral valve) or mitral valve regurgitation (leaky mitral valve) or a mix of the two. TMVR transcatheter mitral valve replacement was developed initially as a method of replacing the mitral valve in patients considered too high risk for surgery but will likely replace mitral valve replacement surgery in the future as the technology improves and the outcomes are proved.
According to our (Global Info Research) latest study, the global Transcatheter Mitral Valve Replacement (TMVR) market size was valued at US$ 1549 million in 2023 and is forecast to a readjusted size of USD 8139 million by 2030 with a CAGR of 27.0% during review period.
The classification of Transcatheter Mitral Valve Replacement (TMVR) includes MitraClip, Edwards PASCAL and Edwards SAPIEN 3. The market share of MitraClip in 2019 reached up to over 96%.
United States and Europe are the largest consumption place, with a revenue market share nearly 96% in 2019. The rest of global market mostly was taken up by China and Japan, which totally occupied a market share of over 2%.
This report is a detailed and comprehensive analysis for global Transcatheter Mitral Valve Replacement (TMVR) market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
Key Features:
Global Transcatheter Mitral Valve Replacement (TMVR) market size and forecasts, in consumption value ($ Million), 2019-2030
Global Transcatheter Mitral Valve Replacement (TMVR) market size and forecasts by region and country, in consumption value ($ Million), 2019-2030
Global Transcatheter Mitral Valve Replacement (TMVR) market size and forecasts, by Type and by Application, in consumption value ($ Million), 2019-2030
Global Transcatheter Mitral Valve Replacement (TMVR) market shares of main players, in revenue ($ Million), 2019-2024
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Transcatheter Mitral Valve Replacement (TMVR)
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Transcatheter Mitral Valve Replacement (TMVR) market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Abbott, Edwards Lifesciences, Medtronic, Boston Scientific, Micro Interventional Devices, Neovasc, LivaNova, HighLife SAS, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Transcatheter Mitral Valve Replacement (TMVR) market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segmentation
Transcatheter Mitral Valve Replacement (TMVR) market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
MitraClip
Edwards PASCAL
Edwards SAPIEN 3
Market segment by Application
Functional Mitral Regurgitation (FMR)
Degenerative Mitral Regurgitation (DMR)
Market segment by players, this report covers
Abbott
Edwards Lifesciences
Medtronic
Boston Scientific
Micro Interventional Devices
Neovasc
LivaNova
HighLife SAS
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Transcatheter Mitral Valve Replacement (TMVR) product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Transcatheter Mitral Valve Replacement (TMVR), with revenue, gross margin, and global market share of Transcatheter Mitral Valve Replacement (TMVR) from 2019 to 2024.
Chapter 3, the Transcatheter Mitral Valve Replacement (TMVR) competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Transcatheter Mitral Valve Replacement (TMVR) market forecast, by regions, by Type and by Application, with consumption value, from 2024 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Transcatheter Mitral Valve Replacement (TMVR).
Chapter 13, to describe Transcatheter Mitral Valve Replacement (TMVR) research findings and conclusion.